Ticker League

Revolution Medicines (RVMD) Profit Bridge

See what drove Revolution Medicines's net income from TTM through Q1 2025 to TTM through Q1 2026 — every line ranked by dollar impact, from revenue gains to taxes.

Analysis
Capital Return

How this company returns cash to shareholders — buybacks, dividends, and stock splits.

TTM

Revenue YoY

Operating Income YoY

-75.68%

Net Income YoY

-96.70%

Net Margin Δ

Net income bridge for Revolution Medicines (RVMD) — TTM through Q1 2026 vs TTM through Q1 2025

Δ Net income: -$674M-96.70%

Profit bridge breakdown for Revolution Medicines (RVMD) — TTM through Q1 2026 vs TTM through Q1 2025

  • Prior Net Income-$698M
  • Revenue$0.00
  • Cost of Revenue-$9.24M
  • Operating Expenses-$588M
  • Other Income / Expense-$76M
  • Income Tax-$753K
  • Net Loss-$1.37B
Identity check: drivers reconcile to ΔNI within $0.00
Want the full P&L structure?Income Statement Waterfall

Frequently asked questions

Data & methodology

Explore more

Deep-dives across the income statement, cash flow, capital return, and valuation